Fight against TB needs $1.6 bn funding annually

Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to mu...

March 19, 2013 | Tuesday | News
Daiichi to aid drug discovery projects

Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...

March 12, 2013 | Tuesday | News
Queensland to get a new drug development center

Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk ann...

June 17, 2015 | Wednesday | News
FDA follows EU, declares Patrys drug as 'orphan'

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal...

November 6, 2013 | Wednesday | News
AbbVie, Galapagos to make drugs for cystic fibrosis mutations

Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel...

September 30, 2013 | Monday | News
Mylan to produce generic of Gilead's HIV drug

Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...

August 3, 2012 | Friday | News
MNCs bet on China to tide over patent cliff

Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has e...

May 16, 2012 | Wednesday | Analysis
Anaphore changes corporate name to RuiYi

Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of n...

October 5, 2012 | Friday | News
Phylogica gets $400K grant to boost drug discovery

Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Cou...

July 22, 2013 | Monday | News
Daiichi gets positive results in prasugrel trial

Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial c...

March 18, 2013 | Monday | News
AstraZeneca acquires Pearl Therapeutics

Singapore: AstraZeneca has completed its acquisition of Pearl Therapeutics, a privately held company based in Redwood Ci...

July 1, 2013 | Monday | News
Target for potent first-strike influenza drugs identified

Singapore: Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely ...

August 3, 2012 | Friday | News
TaiGen gets TFDA nod for bacterial pneumonia drug

Singapore: Taiwan based TaiGen Biotechnology has recieved Taiwan Food and Drug Administration (TFDA) approval for new dr...

March 18, 2014 | Tuesday | Regulatory
Bionomics to raise $16.4 mn for Alzheimer's R&D

Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across d...

March 4, 2013 | Monday | News
Advinus gets $36 mn research funding from Takeda

Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year d...

October 3, 2012 | Wednesday | News
Aslan gastric cancer phase II study shows +ve results

Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...

May 28, 2013 | Tuesday | News
Sanofi, Regeneron cancer drug Zaltrap gets EU nod

Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltr...

February 5, 2013 | Tuesday | News
Low R&D output, patent cliffs drives big pharma nuts

Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...

September 5, 2012 | Wednesday | Analysis